^Katano K, Hayatsu Y, Matsuda T, et al. (November 2007). "Endocapillary proliferative glomerulonephritis with crescent formation and concurrent tubulointerstitial nephritis complicating retroperitoneal fibrosis with a high serum level of IgG4". Clin. Nephrol. 68 (5): 308–14. doi:10.5414/cnp68308. PMID18044263.
^Iwafuchi Y, Morita T, Kamimura A, Kunisada K, Ito K, Miyazaki S (March 2002). "Acute endocapillary proliferative glomerulonephritis associated with human parvovirus B19 infection". Clin. Nephrol. 57 (3): 246–50. PMID11924757.
Further reading
Ito S, Kuriyama H, Iino N, et al. (December 2003). "Patient with diffuse mesangial and endocapillary proliferative glomerulonephritis with hypocomplementemia and elevated anti-streptolysin O treated with prednisolone, angiotensin-converting enzyme inhibitor, and angiotensin II receptor antagonist". Clin. Exp. Nephrol. 7 (4): 290–5. doi:10.1007/s10157-003-0244-0. PMID14712359. S2CID35396896.
Kano K, Nishikura K, Kojima M, et al. (June 2003). "A patient with membranoproliferative glomerulonephritis diagnosed by the third biopsy via endocapillary proliferative glomerulonephritis and focal membranoproliferative glomerulonephritis". Clin. Exp. Nephrol. 7 (2): 157–62. doi:10.1007/s10157-003-0231-5. PMID14586735. S2CID19884818.
